US Politics
AstraZeneca Bows to Pressure: A Victory for Affordable Medicine or Temporary Concession?
AstraZeneca has agreed to lower prescription drug prices for Medicaid under a deal with the Trump administration, matching the lowest prices offered in other developed nations. This long-overdue victory for American consumers demonstrates how relentless pressure can finally break Big Pharma's stranglehold on affordable healthcare, though we must remain vigilant against potential corporate loopholes.
